Calcium channel blockers versus other classes of drugs for hypertension
CONCLUSIONS: For the treatment of hypertension, there is moderate certainty evidence that diuretics reduce major cardiovascular events and congestive heart failure more than CCBs. There is low to moderate certainty evidence that CCBs probably reduce major cardiovascular events more than beta-blockers. There is low to moderate certainty evidence that CCBs reduced stroke when compared to angiotensin-converting enzyme (ACE) inhibitors and reduced myocardial infarction when compared to angiotensin receptor blockers (ARBs), but increased congestive heart failure when compared to ACE inhibitors and ARBs. Many of the differences found in the current review are not robust, and further trials might change the conclusions. More well-designed RCTs studying the mortality and morbidity of individuals taking CCBs as compared with other antihypertensive drug classes are needed for patients with different stages of hypertension, different ages, and with different comorbidities such as diabetes.PMID:34657281 | DOI:10.1002/14651858.CD003654.pub5
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Jiaying Zhu Ning Chen Muke Zhou Jian Guo Cairong Zhu Jie Zhou Mengmeng Ma Li He Source Type: research
More News: Beta-Blockers | Calcium | Cardiology | Cardiovascular | Clinical Trials | Congestive Heart Failure | Databases & Libraries | Diabetes | Endocrinology | General Medicine | Heart | Heart Attack | Heart Failure | Hypertension | International Medicine & Public Health | Men | Stroke | Study | WHO